Patent US4154919A successfully refreshed from Google Patents.
Patent US4766064A successfully refreshed from Google Patents.
US4766064A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Displacement polynucleotide assay employing polyether and diagnostic kit
Assignee: Genetics Institute LLC
•
Filing: 1984-12-20
•
Granted: 1988-08-23
•
Expires: 2004-12-20
Abstract
Abstract A diagnostic reagent is disclosed containing a complex of a probe polynucleotide (P) bound via purine/pyrimidine hydrogen bonding to a labeled polynucleotide (L). The probe (P) contains a target binding region (TBR) capable of binding to a target nucleotide sequence (G) of a biological sample. A method is disclosed in which contact with a sample containing the target nucleotide sequence (G) causes binding, initially between G and a single-stranded portion (IBR) of the target binding region (TBR). Thereafter the labeled polynucleotide (L) is displaced from the complex by branch migration of (G) into the (P)/(L) binding region. A volume excluding polymeric agent such as poly(ethylene oxide) (PEO or PEG) or other polyethers enhances the rate of appearance of displaced labeled polynucleotide. Determination of displaced labeled polynucleotide (L) gives a value which is a function of the presence and concentration of target nucleotide sequence (G) in the sample.
Inventors
- 👤 Jon I. Williams
- 👤 Marian S. Ellwood
- 👤 Mary Collins
- 👤 Edward F. Fritsch
- 👤 Joseph G. Brewen
- 👤 Steven E. Diamond
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 17:24
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6832; C12Q1/6816; C12Q1/6823; C12Q1/6827; C12Q1/6876; Y; Y10; Y10S; Y10S435/00; Y10S435/803; Y10S435/81
Claims Analysis
Total Claims: 36
Claim 1
Independent Claim
188 words
A method for determining the presence of a predetermined target nucleotide sequence in the nucleic acid of a biological sample which comprises the steps: (a) providing a reagent complex of (i) a probe polynucleotide which is capable of base pair binding via hydrogen bonds of purine/pyrimidine bases to the target nucleotide sequence, and (ii) a labeled polynucleotide which is bound by base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in a region of the probe polynucleotide of at least about 20 nucleotides at least partially coextensive with the region in which the probe polynucleotide is capable of binding to the target nucleotide sequence; (b) contacting the reagent complex with a biological sample in the presence of a polyether polymer under conditions in which the target nucleotide sequence, if present in the biological sample, binds to the probe polynucleotide and displaces labeled polynucleotide from the complex, the polyether polymeric agent being of a molecular weight and at a concentration sufficient to increase the rate of appearance of displaced labeled polynucleotide; and (c) determining the presence of labeled polynucleotide displaced from the reagent complex.
Claim 2
Independent Claim
188 words
A method for determining the presence of a predetermined target nucleotide sequence in the nucleic acid of a biological sample which comprises the steps: (a) providing a reagent complex of (i) a probe polynucleotide which is capable of base pair binding via hydrogen bonds of purine/pyrimidine bases to the target nucleotide sequence, and (ii) a labeled polynucleotide which is bound by base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in a region of the probe polynucleotide of at least about 20 nucleotides at least partially coextensive with the region in which the probe polynucleotide is capable of binding to the target nucleotide sequence; (b) contacting the reagent complex with a biological sample in the presence of a polyether polymer under conditions in which the target nucleotide sequence, if present in the biological sample, binds to the probe polynucleotide and displaces labeled polynucleotide from the complex, the polyether polymeric agent being of a molecular weight and at a concentration sufficient to increase the rate of appearance of displaced labeled polynucleotide; and (c) determining the presence of labeled polynucleotide displaced from the reagent complex.
Claim 3
Dependent Claim
17 words
The method of claim 1 wherein the labeled polynucleotide is a polynucleotide bonded to an enzyme label.
Claim 4
Dependent Claim
54 words
The method of claim 1 wherein the probe polynucleotide contains a target binding region capable of base pair binding to the target nucleotide sequence and a labeled polynucleotide binding region bound to bases of the labeled polynucleotide in the complex, and wherein the labeled polynucleotide binding region is contained within the target binding region.
Claim 5
Dependent Claim
21 words
The method of claim 3 wherein the labeled polynucleotide binding region is adjacent to one end of the target binding region.
Claim 6
Dependent Claim
20 words
The method of claim 4 wherein the labeled polynucleotide binding region is about 20 to about 500 nucleotides in length.
Claim 7
Dependent Claim
30 words
The method of claim 5 wherein the portion of the target binding region that is not part of the labeled polynucleotide region is at least about 100 nucleotides in length.
Claim 8
Dependent Claim
19 words
The method of claim 1 wherein the probe polynucleotide is immobilized to a solid support in the reagent complex.
Claim 9
Dependent Claim
20 words
The method of claim 7 wherein the probe polynucleotide is covalently linked to the solid support in the reagent complex.
Claim 10
Dependent Claim
40 words
The method of claim 7 wherein the determining step (c) comprises: (c1) separating a first phase containing immobilized probe polynucleotide from a second phase comprising displaced labeled polynucleotide; and (c2) determining the presence of labeled polynucleotide in the second phase.
Claim 11
Dependent Claim
58 words
The method of claim 9 wherein the probe polynucleotide contains a target binding region capable of base pair binding to the target nucleotide sequence and a labeled polynucleotide binding region bound by purine/pyrimidine base pairing to bases of the labeled polynucleotide in the complex, and wherein the labeled polynucleotide binding region is contained within the target binding region.
Claim 12
Dependent Claim
38 words
The method of claim 10 wherein the probe polynucleotide is attached to the solid substrate adjacent to one end of the probe polynucleotide and the target binding region is adjacent to the opposite end of the probe polynucleotide.
Claim 13
Dependent Claim
18 words
The method of claim 1 wherein the reagent complex is free in solution during the contacting step (b).
Claim 14
Dependent Claim
45 words
The method of claim 12 wherein the determining step (c) comprises: (c1) separating the reagent complex remaining from a portion of the reaction solution after the contacting step (b), and (c2) determining the presence of any displaced labeled polynucleotide in a solution phase after separation.
Claim 15
Dependent Claim
12 words
The method of claim 1 wherein the polyether polymer is poly(propylene glycol).
Claim 16
Dependent Claim
45 words
The method of claim 1 wherein the polyether polymer is a poly(alkylene oxide) of the formula H(O--R) n wherein R is an alkylene moiety of 1-6 carbons and n is an integer, on a weight average molecular weight basis, of about 35 to about 690.
Claim 17
Dependent Claim
12 words
The method of claim 1 wherein the polyether polymer is poly(ethylene oxide).
Claim 18
Dependent Claim
20 words
The method of claim 16 wherein the poly(ethylene oxide) is of weight average molecular weight of at least about 1500.
Claim 19
Dependent Claim
20 words
The method of claim 16 wherein the poly(ethylene oxide) is of weight average molecular weight of at least about 2500.
Claim 20
Dependent Claim
167 words
A diagnostic kit for determining the presence of a predetermined target nucleotide sequence in the nucleic acid of a biological sample comprising: (a) the reagent complex of: (i) a probe polynucleotide which is capable of base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the target nucleotide sequence, and (ii) a labeled polynucleotide which is bound by base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in a region of the probe polynucleotide of at least about 20 nucleotides at least partially coextensive with the region in which the probe polynucleotide is capable of base pair binding to the target nucleotide sequence; the potential base pair binding between the target nucleotide sequence and the probe polynucleotide being capable of displacing the labeled polynucleotide from the reagent complex, and (b) a volume-excluding inert polymeric agent which is non-ionic or anionic of sufficient molecular weight and amount relative to the reagent complex to increase the rate of appearance of displaced labeled polynucleotide.
Claim 21
Dependent Claim
167 words
A diagnostic kit for determining the presence of a predetermined target nucleotide sequence in the nucleic acid of a biological sample comprising: (a) the reagent complex of: (i) a probe polynucleotide which is capable of base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the target nucleotide sequence, and (ii) a labeled polynucleotide which is bound by base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in a region of the probe polynucleotide of at least about 20 nucleotides at least partially coextensive with the region in which the probe polynucleotide is capable of base pair binding to the target nucleotide sequence; the potential base pair binding between the target nucleotide sequence and the probe polynucleotide being capable of displacing the labeled polynucleotide from the reagent complex, and (b) a volume-excluding inert polymeric agent which is non-ionic or anionic of sufficient molecular weight and amount relative to the reagent complex to increase the rate of appearance of displaced labeled polynucleotide.
Claim 22
Dependent Claim
29 words
The diagnostic kit of claim 19 wherein the region of the probe polynucleotide to which the labeled polynucleotide is bound is about 20 to about 1000 nucleotides in length.
Claim 23
Dependent Claim
160 words
A diagnostic kit for determining the presence of a predetermined target nucleotide sequence in the nucleic acid of a biological sample comprising: (a) the reagent complex of: (i) a probe polynucleotide which is capable of base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the target nucleotide sequence, and (ii) a labeled polynucleotide which is bound by base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in a region of the probe polynucleotide of at least about 20 nucleotides at least partially coextensive with the region in which the probe polynucleotide is capable of base pair binding to the target nucleotide sequence; the potential base pair binding between the target nucleotide sequence and the probe polynucleotide being capable of displacing the labeled polynucleotide from the reagent complex, and (b) a polyether polymer of sufficient molecular weight and amount relative to the reagent complex to increase the rate of appearance of displaced labeled polynucleotide.
Claim 24
Dependent Claim
160 words
A diagnostic kit for determining the presence of a predetermined target nucleotide sequence in the nucleic acid of a biological sample comprising: (a) the reagent complex of: (i) a probe polynucleotide which is capable of base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the target nucleotide sequence, and (ii) a labeled polynucleotide which is bound by base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in a region of the probe polynucleotide of at least about 20 nucleotides at least partially coextensive with the region in which the probe polynucleotide is capable of base pair binding to the target nucleotide sequence; the potential base pair binding between the target nucleotide sequence and the probe polynucleotide being capable of displacing the labeled polynucleotide from the reagent complex, and (b) a polyether polymer of sufficient molecular weight and amount relative to the reagent complex to increase the rate of appearance of displaced labeled polynucleotide.
Claim 25
Dependent Claim
44 words
The diagnostic kit of claim 21 wherein the polyether polymer agent is a poly(alkylene oxide) of the formula H(O--R) n --H wherein R is alkylene of 1-6 carbons and n is an integer, on a weight average basis, of about 35 to about 690.
Claim 26
Dependent Claim
13 words
The diagnostic kit of claim 21 wherein the polyether polymer is poly(ethylene oxide).
Claim 27
Dependent Claim
20 words
The diagnostic kit of claim 21 wherein the poly(ethylene oxide) is of weight average molecular weight at least about 1500.
Claim 28
Dependent Claim
20 words
The diagnostic kit of claim 24 wherein the poly(ethylene oxide) is of weight average molecular weight at least about 2500.
Claim 29
Dependent Claim
12 words
The diagnostic kit of claim 21 wherein the polyether is poly(propylene glycol).
Claim 30
Independent Claim
196 words
A method for determining the presence of a predetermined target nucleotide sequence in the nucleic acid of a biological sample which comprises the steps: (a) providing a reagent complex of (i) a probe polynucleotide which is capable of base pair binding via hydrogen bonds of purine/pyrimidine bases to the target nucleotide sequence, and (ii) a labeled polynucleotide which is bound by base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in a region of the probe polynucleotide of at least about 20 nucleotides at least partially coextensive with the region in which the probe polynucleotide is capable of binding to the target nucleotide sequence; (b) contacting the reagent complex with a biological sample in the presence of a volume-excluding inert polymeric agent which is non-ionic or anionic under conditions in which the target nucleotide sequence, if present in the biological sample, binds to the probe polynucleotide and displaces labeled polynucleotide from the complex, the volume-excluding inert polymeric agent being of a molecular weight and at a concentration sufficient to increase the rate of appearance of displaced labeled polynucleotide; and (c) determining the presence of labeled polynucleotide displaced from the reagent complex.
Claim 31
Independent Claim
196 words
A method for determining the presence of a predetermined target nucleotide sequence in the nucleic acid of a biological sample which comprises the steps: (a) providing a reagent complex of (i) a probe polynucleotide which is capable of base pair binding via hydrogen bonds of purine/pyrimidine bases to the target nucleotide sequence, and (ii) a labeled polynucleotide which is bound by base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in a region of the probe polynucleotide of at least about 20 nucleotides at least partially coextensive with the region in which the probe polynucleotide is capable of binding to the target nucleotide sequence; (b) contacting the reagent complex with a biological sample in the presence of a volume-excluding inert polymeric agent which is non-ionic or anionic under conditions in which the target nucleotide sequence, if present in the biological sample, binds to the probe polynucleotide and displaces labeled polynucleotide from the complex, the volume-excluding inert polymeric agent being of a molecular weight and at a concentration sufficient to increase the rate of appearance of displaced labeled polynucleotide; and (c) determining the presence of labeled polynucleotide displaced from the reagent complex.
Claim 32
Dependent Claim
13 words
The method of claim 27 wherein the volume-excluding inert polymeric agent is non-ionic.
Claim 33
Dependent Claim
21 words
The method of claim 27 wherein the non-ionic volume excluding inert polymer is the reaction product of a sugar with epichlorohydrin.
Claim 34
Dependent Claim
12 words
The method of claim 27 wherein the volume-excluding inert polymer is anionic.
Claim 35
Independent Claim
188 words
A method for determining the presence of a predetermined target nucleotide sequence in the nucleic acid of a biological sample which comprises the steps: (a) providing a reagent complex of (i) a probe polynucleotide which is capable of base pair binding via hydrogen bonds of purine/pyrimidine bases to the target nucleotide sequence, and (ii) a labeled polynucleotide which is bound by base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in a region of the probe polynucleotide of at least about 20 nucleotides at least partially coextensive with the region in which the probe polynucleotide is capable of binding to the target nucleotide sequence; (b) contacting the reagent complex with a biological sample in the presence of a polyether polymer under conditions in which the target nucleotide sequence, if present in the biological sample, binds to the probe polynucleotide and displaces labeled polynucleotide from the complex, the polyether polymeric agent being of a molecular weight and at a concentration sufficient to increase the rate of appearance of displaced labeled polynucleotide; and (c) determining the presence of labeled polynucleotide remaining in the reagent complex.
Claim 36
Independent Claim
188 words
A method for determining the presence of a predetermined target nucleotide sequence in the nucleic acid of a biological sample which comprises the steps: (a) providing a reagent complex of (i) a probe polynucleotide which is capable of base pair binding via hydrogen bonds of purine/pyrimidine bases to the target nucleotide sequence, and (ii) a labeled polynucleotide which is bound by base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in a region of the probe polynucleotide of at least about 20 nucleotides at least partially coextensive with the region in which the probe polynucleotide is capable of binding to the target nucleotide sequence; (b) contacting the reagent complex with a biological sample in the presence of a polyether polymer under conditions in which the target nucleotide sequence, if present in the biological sample, binds to the probe polynucleotide and displaces labeled polynucleotide from the complex, the polyether polymeric agent being of a molecular weight and at a concentration sufficient to increase the rate of appearance of displaced labeled polynucleotide; and (c) determining the presence of labeled polynucleotide remaining in the reagent complex.
References Cited (Backward Citations)
US3798320A
Cited
US4205952A
Cited
US4388295A
Cited
US4302204A
Cited
US4358535A
Cited
US4358535B1
Cited
EP0063879A2
Cited
EP0070687B1
Cited
US4486539A
Cited
EP0097373B1
Cited
US4434236A
Cited
EP0124221A1
Cited
EP0133288A2
Cited
EP0139489A2
Cited
US4629689A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-08-23 | 1992-02-22 | 1992-08-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-08-23 | 1996-02-22 | 1996-08-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-08-23 | 2000-02-22 | 2000-08-23 | $7700.00 | Window Closed / Lapsed |